Encompass Health’s (EHC) Outperform Rating Reaffirmed at Royal Bank of Canada

Encompass Health (NYSE:EHC)‘s stock had its “outperform” rating reaffirmed by investment analysts at Royal Bank of Canada in a research report issued to clients and investors on Tuesday,Benzinga reports. They presently have a $110.00 price target on the stock. Royal Bank of Canada’s price objective points to a potential upside of 10.34% from the stock’s current price.

Several other equities research analysts have also commented on the company. Truist Financial restated a “buy” rating and issued a $116.00 price objective (up from $108.00) on shares of Encompass Health in a research note on Wednesday, October 30th. KeyCorp raised their price target on Encompass Health from $117.00 to $120.00 and gave the company an “overweight” rating in a report on Monday. William Blair reiterated an “outperform” rating on shares of Encompass Health in a research report on Friday. Barclays increased their price objective on shares of Encompass Health from $116.00 to $118.00 and gave the stock an “overweight” rating in a research report on Friday. Finally, StockNews.com downgraded shares of Encompass Health from a “buy” rating to a “hold” rating in a research note on Friday. One analyst has rated the stock with a hold rating, nine have assigned a buy rating and two have given a strong buy rating to the company. Based on data from MarketBeat.com, Encompass Health presently has a consensus rating of “Buy” and an average target price of $107.67.

Encompass Health Stock Up 1.1 %

Shares of NYSE EHC traded up $1.06 during mid-day trading on Tuesday, hitting $99.69. 211,294 shares of the stock traded hands, compared to its average volume of 650,936. The company has a debt-to-equity ratio of 0.88, a quick ratio of 1.04 and a current ratio of 1.04. The stock has a fifty day moving average price of $96.20 and a 200-day moving average price of $95.35. The company has a market cap of $10.04 billion, a price-to-earnings ratio of 22.31, a PEG ratio of 1.18 and a beta of 0.90. Encompass Health has a 52 week low of $72.38 and a 52 week high of $104.55.

Encompass Health (NYSE:EHC) last released its quarterly earnings data on Thursday, February 6th. The company reported $1.17 earnings per share for the quarter, beating analysts’ consensus estimates of $1.05 by $0.12. Encompass Health had a net margin of 8.48% and a return on equity of 18.06%. Research analysts anticipate that Encompass Health will post 4.76 EPS for the current year.

Hedge Funds Weigh In On Encompass Health

Several institutional investors have recently modified their holdings of the business. MassMutual Private Wealth & Trust FSB raised its stake in Encompass Health by 87.8% during the 4th quarter. MassMutual Private Wealth & Trust FSB now owns 293 shares of the company’s stock worth $27,000 after acquiring an additional 137 shares in the last quarter. UMB Bank n.a. boosted its holdings in Encompass Health by 387.7% in the 3rd quarter. UMB Bank n.a. now owns 317 shares of the company’s stock valued at $31,000 after purchasing an additional 252 shares in the last quarter. V Square Quantitative Management LLC grew its holdings in Encompass Health by 53.0% during the third quarter. V Square Quantitative Management LLC now owns 404 shares of the company’s stock worth $39,000 after acquiring an additional 140 shares during the period. Avior Wealth Management LLC purchased a new position in shares of Encompass Health in the 3rd quarter valued at about $40,000. Finally, CBIZ Investment Advisory Services LLC boosted its stake in shares of Encompass Health by 38.7% during the 4th quarter. CBIZ Investment Advisory Services LLC now owns 455 shares of the company’s stock worth $42,000 after acquiring an additional 127 shares in the last quarter. Institutional investors and hedge funds own 97.25% of the company’s stock.

Encompass Health Company Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.